Understanding the Heart-Hearing Connection
At a Glance
Sensorineural hearing loss and dilated cardiomyopathy can be linked by a shared genetic condition, including mitochondrial disorders. Genetic evaluation and coordinated heart, hearing, and family monitoring help guide care.
When a diagnosis involves both the heart and the hearing, it can feel like you are being pulled into two different worlds. You may be navigating cardiology (heart care) and audiology (hearing care) simultaneously, which can feel overwhelming. It is important to know that while this combination is rare, it is a well-recognized medical presentation known as a cardio-auditory phenotype [1].
This term describes a situation where a genetic cause or mechanism affects both the cochlea (the inner ear’s hearing organ) and the myocardium (the heart muscle) [2][3]. Understanding this as a descriptive pattern rather than two completely unrelated diseases can help you and your care team coordinate treatment more effectively.
Understanding the Rarity
The combination of sensorineural hearing loss (hearing loss caused by inner ear or nerve damage) and dilated cardiomyopathy (a condition where the heart’s main pumping chamber becomes enlarged and weakened) is quite rare. For example, Alström syndrome, one of the conditions that can cause this combination, is estimated to affect fewer than 1 in 1,000,000 people [4].
Because these conditions are uncommon, you may be the first person your local specialist has seen with this specific combination. However, specialized research centers have studied these genetic conditions for decades, providing a roadmap for what to expect and how to manage care [5].
Examples of Genetic Causes
Most cases of this phenotype are caused by specific genetic mechanisms, though finding the exact one can take time, and a genetic test can be negative or show a variant of uncertain significance. Some well-studied examples include:
- EYA4 Variants: This is often an autosomal dominant condition, meaning it can be passed down from a single parent who carries the gene [3]. In many families, the hearing loss is postlingual (occurring after a child has learned to speak) and progressive [2][6]. The heart involvement, specifically dilated cardiomyopathy (DCM), may appear later or alongside the hearing changes, though penetrance and progression vary even within a family [1].
- Alström Syndrome: This is an autosomal recessive condition, occurring when a child inherits a mutated gene from both parents. It often involves childhood hearing loss and heart issues, but may also include other symptoms like vision loss, obesity, or diabetes [7][5].
- Mitochondrial Disorders: These conditions affect cellular energy. Because the heart and the inner ear both require a massive amount of energy to function, they are often affected [8]. Mitochondrial disorders may result from nuclear genes (inherited recessively) or from mitochondrial DNA (inherited from the mother or occurring spontaneously) [9].
How Timelines May Differ
One of the most confusing aspects of these syndromes is that hearing loss and heart disease do not always start at the same time. These are not rules for every person, but rather examples of how timelines can differ:
- Hearing-First Presentation: In some cases, especially with certain EYA4 variants or mitochondrial disorders, hearing loss is detected years or even decades before any heart symptoms appear [10][6].
- Simultaneous Onset: In some rare infantile conditions, such as those related to the DNAJC19 gene, heart issues and neurological or metabolic features may be diagnosed within the first few months of life, with hearing loss sometimes identified at the same time [11].
- Heart-First or Variable Presentation: In Alström syndrome, heart issues can fluctuate; some infants experience early heart failure that improves, only for it to return later in life, while hearing loss often progresses during childhood [7][12]. Serial heart and hearing tests matter more than a timeline alone.
Navigating the Two Systems
Because you are managing two major systems, your care will involve a “team-based” approach.
- Audiology and ENT: These specialists focus on maximizing hearing through tools like hearing aids or cochlear implants (surgically implanted devices that provide a sense of sound) [13][14].
- Cardiology: These specialists focus on the ejection fraction (a measure of how much blood the heart pumps out with each contraction) and may use medications to support heart function [1].
While it feels like you are managing two separate battles, modern genetic testing and specialized care guidelines are designed to help your doctors look at the “big picture” rather than just the individual symptoms [15][9].
Common questions in this guide
What does a cardio-auditory phenotype mean?
Can the same genetic condition cause hearing loss and dilated cardiomyopathy?
Which conditions are linked with hearing loss and heart problems?
Does hearing loss always happen before heart disease?
How are heart and hearing problems monitored together?
What treatments may help when hearing loss occurs with cardiomyopathy?
Get notified when new evidence is published on Sensorineural deafness with dilated cardiomyopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Genome-first approach to rare EYA4 variants and cardio-auditory phenotypes in adults.
Ahmadmehrabi S, Li B, Park J, et al.
Human genetics 2021; (140(6)):957-967 doi:10.1007/s00439-021-02263-6.
PMID: 33745059 - 2
Audiometric Characteristics of a Dutch DFNA10 Family With Mid-Frequency Hearing Impairment.
van Beelen E, Oonk AM, Leijendeckers JM, et al.
Ear and hearing 2016; (37(1)):103-11 doi:10.1097/AUD.0000000000000217.
PMID: 26331839 - 3
Sensorineural hearing loss and mild cardiac phenotype caused by an EYA4 mutation.
Abe S, Takeda H, Nishio SY, Usami SI
Human genome variation 2018; (5()):23 doi:10.1038/s41439-018-0023-9.
PMID: 30155266 - 4
Prevalent ALMS1 Pathogenic Variants in Spanish Alström Patients.
Bea-Mascato B, Solarat C, Perea-Romero I, et al.
Genes 2021; (12(2)) doi:10.3390/genes12020282.
PMID: 33669459 - 5
Consensus clinical management guidelines for Alström syndrome.
Tahani N, Maffei P, Dollfus H, et al.
Orphanet journal of rare diseases 2020; (15(1)):253 doi:10.1186/s13023-020-01468-8.
PMID: 32958032 - 6
Novel EYA4 variant in Slovak family with late onset autosomal dominant hearing loss: a case report.
Varga L, Danis D, Skopkova M, et al.
BMC medical genetics 2019; (20(1)):84 doi:10.1186/s12881-019-0806-y.
PMID: 31101089 - 7
Auditory and otologic profile of Alström syndrome: Comprehensive single center data on 38 patients.
Lindsey S, Brewer C, Stakhovskaya O, et al.
American journal of medical genetics. Part A 2017; (173(8)):2210-2218 doi:10.1002/ajmg.a.38316.
PMID: 28573831 - 8
A retrospective cohort study exploring the association between different mitochondrial diseases and hearing loss.
van Kempen CMA, Beynon AJ, Smits JJ, Janssen MCH
Molecular genetics and metabolism 2022; (135(4)):333-341 doi:10.1016/j.ymgme.2022.02.003.
PMID: 35190254 - 9
The heart in m.3243A>G carriers.
Finsterer J, Zarrouk-Mahjoub S
Herz 2020; (45(4)):356-361 doi:10.1007/s00059-018-4739-6.
PMID: 30128910 - 10
The Importance of Mitochondrial Disease Testing in Young Adults With New Onset Sensorineural Hearing Loss.
Koleilat A, Poling GL, Schimmenti LA, Hasadsri L
Ear and hearing 2024; (45(2)):517-521 doi:10.1097/AUD.0000000000001442.
PMID: 37930162 - 11
Previously Unreported Biallelic Mutation in DNAJC19: Are Sensorineural Hearing Loss and Basal Ganglia Lesions Additional Features of Dilated Cardiomyopathy and Ataxia (DCMA) Syndrome?
Ucar SK, Mayr JA, Feichtinger RG, et al.
JIMD reports 2017; (35()):39-45 doi:10.1007/8904_2016_23.
PMID: 27928778 - 12
A novel homozygous ALMS1 protein truncation mutation (c.2938dupA) revealed variable clinical expression among Saudi Alström syndrome patients.
Bdier AY, Al-Qahtani FA, Verma PK, et al.
Archives of medical science : AMS 2026; (22(4)):2197-2204 doi:10.5114/aoms.2020.100635.
PMID: 42877687 - 13
Characteristics of Hearing Loss in Patients with COL2A1 Gene Variants (Sticker Syndrome Type 1).
Fábrega-Torrano M, González-Aguado R, Onecha E, Morales-Angulo C
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India 2025; (77(8)):3091-3098 doi:10.1007/s12070-025-05638-7.
PMID: 40727136 - 14
Bilateral Enlarged Vestibular Aqueduct: Auditory, Genetic and Radiological Characterization, and Benefits of Cochlear Implants.
Vigouroux A, Glemain B, Torres R, et al.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2025; (173(5)):1215-1227 doi:10.1002/ohn.1375.
PMID: 40760936 - 15
Identification of a novel truncation mutation of EYA4 in moderate degree hearing loss by targeted exome sequencing.
Choi HS, Kim AR, Kim SH, Choi BY
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2016; (273(5)):1123-9 doi:10.1007/s00405-015-3661-2.
PMID: 26015337
This page explains the heart-and-hearing pattern and possible genetic causes for educational purposes; it does not replace medical advice. Your cardiology, audiology or ENT, and genetics teams can interpret your results and plan monitoring.